DCM
ACGN

Driehaus Capital Management’s Aceragen Inc ACGN Stock Holding History

Driehaus Capital Management’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,166
Closed -$2.17M – 662
2015
Q4 		$2.17M Buy
+5,166
New +$2.31M 0.07% 283

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Driehaus Capital Management's ACGN Position: Q1 2016 in Review

Driehaus Capital Management sold out of Aceragen Inc (ACGN) in Q1 2016, closing a stake of 5,166 shares — an estimated $2.17M sold.

Driehaus Capital Management first reported a position in ACGN in Q4 2015 and held it in 1 quarter. The position peaked at $2.17M in Q4 2015. 80 funds tracked by Wall St. Rank hold ACGN as of Q1 2016.

  • Driehaus Capital Management reported no remaining Aceragen Inc position as of Q1 2016 after selling out during the quarter.
  • Driehaus Capital Management sold 5,166 Aceragen Inc shares in Q1 2016, an estimated $2.17M.
  • Driehaus Capital Management first reported a position in Aceragen Inc in Q4 2015 and held it in 1 quarter.
  • Driehaus Capital Management's Aceragen Inc position peaked at $2.17M in Q4 2015.
  • 80 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2016.

Based on Driehaus Capital Management's 13F filing for Q1 2016, filed 13 May 2016.